Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Heal

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Current Topics in Behavioral Neurosciences|May 4, 2022
New Drugs to Treat ADHD: Opportunities and Challenges in Research and DevelopmentDavid J Heal, Jane Gosden, Sharon L Smith
Journal of Psychopharmacology (Oxford, England)|July 28, 2016
The NK1R-/- mouse phenotype suggests that small body size, with a sex- and diet-dependent excess in body mass and fat, are physical biomarkers for a human endophenotype with vulnerability to attention deficit hyperactivity disorderKatharine Pillidge, David J Heal, S Clare Stanford
Neuropharmacology|June 24, 2014
Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaineDavid J Heal, Jane Gosden, Sharon L Smith
Neuropharmacology|February 11, 2018
Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humansDavid J Heal, Jane Gosden, Sharon L Smith
British Journal of Clinical Pharmacology|December 17, 2009
Regulatory challenges for new drugs to treat obesity and comorbid metabolic disordersDavid J Heal, Jane Gosden, Sharon L Smith
Frontiers in Psychiatry|June 25, 2024
A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoidsDavid J Heal, Jane Gosden, Sharon L Smith
Current Topics in Behavioral Neurosciences|April 14, 2011
ADHD: current and future therapeuticsDavid J Heal, Sharon L Smith, Robert L Findling
Journal of Psychopharmacology (Oxford, England)|December 1, 2025
Psychedelic research - Going globalDavid J Heal, Sharon L Smith, Jack E Henningfield
British Journal of Pharmacology|August 19, 2003
Differences in the mechanisms that increase noradrenaline efflux after administration of d-amphetamine: a dual-probe microdialysis study in rat frontal cortex and hypothalamusSandrine M Géranton, David J Heal, S Clare Stanford
Neuropharmacology|April 22, 2014
Contrasting changes in extracellular dopamine and glutamate along the rostrocaudal axis of the anterior cingulate cortex of the rat following an acute d-amphetamine or dopamine challengeElizabeth S Ash, David J Heal, S Clare Stanford
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Current Topics in Behavioral Neurosciences|May 4, 2022
New Drugs to Treat ADHD: Opportunities and Challenges in Research and DevelopmentDavid J Heal, Jane Gosden, Sharon L Smith
Journal of Psychopharmacology (Oxford, England)|July 28, 2016
The NK1R-/- mouse phenotype suggests that small body size, with a sex- and diet-dependent excess in body mass and fat, are physical biomarkers for a human endophenotype with vulnerability to attention deficit hyperactivity disorderKatharine Pillidge, David J Heal, S Clare Stanford
Neuropharmacology|June 24, 2014
Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaineDavid J Heal, Jane Gosden, Sharon L Smith
Neuropharmacology|February 11, 2018
Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humansDavid J Heal, Jane Gosden, Sharon L Smith
British Journal of Clinical Pharmacology|December 17, 2009
Regulatory challenges for new drugs to treat obesity and comorbid metabolic disordersDavid J Heal, Jane Gosden, Sharon L Smith
Frontiers in Psychiatry|June 25, 2024
A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoidsDavid J Heal, Jane Gosden, Sharon L Smith
Current Topics in Behavioral Neurosciences|April 14, 2011
ADHD: current and future therapeuticsDavid J Heal, Sharon L Smith, Robert L Findling
Journal of Psychopharmacology (Oxford, England)|December 1, 2025
Psychedelic research - Going globalDavid J Heal, Sharon L Smith, Jack E Henningfield
British Journal of Pharmacology|August 19, 2003
Differences in the mechanisms that increase noradrenaline efflux after administration of d-amphetamine: a dual-probe microdialysis study in rat frontal cortex and hypothalamusSandrine M Géranton, David J Heal, S Clare Stanford
Neuropharmacology|April 22, 2014
Contrasting changes in extracellular dopamine and glutamate along the rostrocaudal axis of the anterior cingulate cortex of the rat following an acute d-amphetamine or dopamine challengeElizabeth S Ash, David J Heal, S Clare Stanford
Pageof 5